Omphalos Lifesciences

cropped-img_logo_omphalos.png
Menu

Blog page

Omphalos Signs MOU with FuriosaAI, KRIBB KPEC, Yonsei University, and Insilicox

We are excited to share that Omphalos Lifesciences Inc has joined a new industryโ€“academiaโ€“research consortium to accelerate ๐—”๐—œ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜‚๐˜€๐—ถ๐—ป๐—ด ๐—ป๐—ฒ๐˜…๐˜-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ถ๐—ป๐—ด ๐—ถ๐—ป๐—ณ๐—ฟ๐—ฎ๐˜€๐˜๐—ฟ๐˜‚๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ. On March 13, Omphalos Korea signed an MOU with FuriosaAI, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Korea Preclinical Evaluation Center (KPEC), Yonsei University College of Pharmacy, and Insilicox to build a collaborative ecosystem for AI-powered drug development. This partnership aims to integrate domestic NPU-based AI computing infrastructure with advanced Read more…

By Omphalos Lifesciences, ago

Joint Research Agreement with Institut Pasteur Korea

We are pleased to announce a ๐‰๐จ๐ข๐ง๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ ๐ซ๐ž๐ž๐ฆ๐ž๐ง๐ญ with Institut Pasteur Korea (IPK), a world-leading center for infectious disease research and a state-of-the-art scientific hub within the global Pasteur Network. IPK is internationally recognized for its advanced research infrastructure, including BSL-3 laboratory capabilities and high-throughput screening platforms that support rigorous infectious disease and therapeutic discovery programs. Through this agreement, Omphalos will collaborate with IPK on joint research to advance new approaches for building and Read more…

By Omphalos Lifesciences, ago

Omphalos Secures BARDA Support for Pathogen-Agnostic Antimicrobial Strategy Simulation

We are excited to share that Omphalos Lifesciences Inc has been selected to receive non-dilutive support from Biomedical Advanced Research and Development Authority (BARDA) through MATTERโ€™s Paratus digital health program! ๐Ÿ‘‰ Read the full article on MATTERโ€™s website This support enables us to advance our ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐š๐›๐ฅ๐ž ๐ฏ๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐œ๐ž๐ฅ๐ฅ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ by developing next-generation computational models of high-priority, hospital-acquired pathogens. Our work aligns with BARDAโ€™s mission to accelerate new therapeutic strategies for antimicrobial resistance (#AMR) and demonstrates Read more…

By Omphalos Lifesciences, ago

Omphalos Lifesciences Wins Award at PARATUS Digital Health Accelerator Showcase

Omphalos is honored to have been selected as one of the award recipients at the Paratus Digital Health Accelerator final showcase. ๐Ÿ‘‰ Read the full article and videos on MATTERโ€™s website We extend our sincere thanks to MATTER, the mentors, and our fellow innovators (Ad Astra Diagnostics, Inc. and SHADDARI (Google ’22)) for their contributions to advancing digital health. This recognition reinforces our commitment to advancing simulation-based, future-proof antibiotic R&D, aligned with BARDAโ€™s priorities to Read more…

By Omphalos Lifesciences, ago

Omphalos Selected for BARDA-Backed Paratus Digital Health Accelerator

Weโ€™re excited to share that Omphalos Lifesciences Inc has been selected for MATTERโ€™s Paratus Digital Health Accelerator, part of the Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network! ๐Ÿ‘‰ Read the full article on MATTERโ€™s website At Omphalos, we believe that programming biology is the key to building fast, flexible, and threat-agnostic solutions for national health security. Our #VirtualCell platform turns biological systems into programmable, testable models, unlocking a new approach to pathogen and Read more…

By Omphalos Lifesciences, ago

NVIDIA Inception Program

Weโ€™re excited to share that Omphalos Lifesciences Inc is now part of the NVIDIA Inception Program! Our work sits at the intersection of #biology and #computation. We’re building a new #foundation and #infrastructure for life sciences, one where cells can be written, simulated, and optimized like software. Our #VirtualCell technology brings this vision closer to reality, and joining the NVIDIA Inception gives us the tools and support to scale it further. With access to NVIDIAโ€™s Read more…

By Omphalos Lifesciences, ago

Bacterial Chemotaxis Part 2

We previously published a post about a model of bacterial chemotaxis in which we discussed the chemotaxis behavior in an individual E. coli, its biological function, and the mechanical forces that drive it. Using a model described by Dr. Brian Ingalls, we provided a program that would simulate bacterial chemotaxis behavior. When we design models of biological systems we want to not only capture the behavior involved, but also the biological forces that make it Read more…

By Omphalos Lifesciences, ago

Specification for Biosystems in the Presence of Unknowns

In our last post we discussed how two abstractions in L++ can be implemented to create highly specific and detailed descriptions of biosystems; however, before any design is implemented we should know how the final product should be assembled and how it should behave when it is complete. L++ allows for users to design their own specification for a biosystem before additionally building it. This allows for the inclusion of all of the chemical and Read more…

By Omphalos Lifesciences, ago

Two abstractions of L++ enables the precise description of biosystems

At first glance any system can look like a complicated web of components; however, itโ€™s important to not get bogged down in every tiny detail. If you were given a recipe, you would only be required to know basic details like which ingredients to use, and how to prepare and heat them. You would not require instructions detailing which knife to use for the job or how to generate the heat needed to prepare your Read more…

By Omphalos Lifesciences, ago

Life in light of atoms, molecules, and proteins

What we now call Biology used to be considered โ€œmagicโ€. Before Germ Theory, developed in the mid-nineteenth century, diseases were often associated with demons and other malicious creatures of myth. Take tuberculosis for example, the disease that gave rise to the myth of the vampire. The more we have learned about life the further Biology has separated from mystical practices, so letโ€™s break life down to its basics and evaluate the organization behind Lifeโ€™s structure. Read more…

By Omphalos Lifesciences, ago